Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.

PubWeight™: 1.60‹?› | Rank: Top 4%

🔗 View Article (PMC 3853378)

Published in Obesity (Silver Spring) on February 01, 2013

Authors

Mandeep Singh1, Jaehoon Lee, Neil Gupta, Srinivas Gaddam, Bryan K Smith, Sachin B Wani, Debra K Sullivan, Amit Rastogi, Ajay Bansal, Joseph E Donnelly, Prateek Sharma

Author Affiliations

1: Department of Gastroenterology, Veterans Affairs Medical Center, Kansas City, Missouri, USA.

Associated clinical trials:

Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy (GERD) | NCT03705416

Articles citing this

Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol (2015) 1.47

Symptomatic reflux disease: the present, the past and the future. Gut (2014) 1.29

The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol (2014) 0.90

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care (2015) 0.86

Gastro-esophageal reflux disease and obesity, where is the link? World J Gastroenterol (2013) 0.83

A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes (2013) 0.81

Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi. World J Gastroenterol (2012) 0.81

Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations. Ther Adv Chronic Dis (2015) 0.80

Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J (2015) 0.78

Obesity and GERD. Gastroenterol Clin North Am (2013) 0.78

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol (2015) 0.75

GERD: GERD symptoms can resolve in overweight and obese people who lose weight. Nat Rev Gastroenterol Hepatol (2012) 0.75

Impact of obesity treatment on gastroesophageal reflux disease. World J Gastroenterol (2016) 0.75

Medical Treatment of Gastroesophageal Reflux Disease. World J Surg (2017) 0.75

The Quality of Care for Gastroesophageal Reflux Disease. Dig Dis Sci (2016) 0.75

Gastrointestinal Complications of Obesity. Gastroenterology (2017) 0.75

Gastroesophageal Reflux Disease and its Association with Body Mass Index: Clinical and Endoscopic Study. J Clin Diagn Res (2017) 0.75

Articles cited by this

Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol (2005) 3.86

Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med (2006) 3.84

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93

Gastroesophageal reflux among different racial groups in the United States. Gastroenterology (2004) 2.87

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol (2005) 2.60

Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol (2003) 2.46

Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol (2006) 2.26

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23

Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg (2007) 1.97

Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 1.86

Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol (1996) 1.70

Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol (2006) 1.65

Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut (2004) 1.47

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47

Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol (2004) 1.36

Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc (2002) 1.30

A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol (1989) 1.28

Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol (2008) 1.28

The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes (2008) 1.18

Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol (2009) 1.18

Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol (1996) 1.11

Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol (1999) 1.03

Esophageal motility and reflux symptoms before and after bariatric surgery. Obes Surg (2002) 1.00

The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg (2010) 0.96

Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2009) 0.95

Association between weight gain and symptoms of gastroesophageal reflux in the general population. Am J Gastroenterol (2006) 0.93

A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci (2006) 0.90

Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients. Obesity (Silver Spring) (2006) 0.88

Vertical banded gastroplasty as an antireflux procedure. Am J Surg (1988) 0.84

Gastroesophageal reflux in the massively obese. Int Surg (1987) 0.84

Neither low-calorie diet nor vertical banded gastroplasty influence gastro-oesophageal reflux in morbidly obese patients. Eur J Surg (2000) 0.80

Articles by these authors

HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A (2002) 17.22

Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91

American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc (2009) 6.07

American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93

Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol (2013) 4.31

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44

Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut (2012) 3.30

Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial. Arch Intern Med (2003) 2.83

Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc (2007) 2.77

The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc (2006) 2.71

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imaging. Gastrointest Endosc (2013) 2.53

The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51

Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc (2011) 2.51

American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50

Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol (2009) 2.46

Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc (2010) 2.38

Component Level Modular Design of a Solid State X-ray Image Intensifier for an M×N Array. IEEE Nucl Sci Symp Conf Rec (1997) (2010) 2.28

Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res (2013) 2.28

Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology (2011) 2.27

Water quality modelling of the river Yamuna (India) using QUAL2E-UNCAS. J Environ Manage (2006) 2.27

Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2010) 2.24

Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol (2013) 2.10

Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. Eur J Gastroenterol Hepatol (2016) 2.06

Physical Activity Across the Curriculum (PAAC): a randomized controlled trial to promote physical activity and diminish overweight and obesity in elementary school children. Prev Med (2009) 2.04

Fruit, vegetable, and fat intake among non-Hispanic black and non-Hispanic white adolescents: associations with home availability and food consumption settings. J Am Diet Assoc (2006) 2.00

Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease. Alzheimer Dis Assoc Disord (2009) 1.99

Resistance to exercise-induced weight loss: compensatory behavioral adaptations. Med Sci Sports Exerc (2013) 1.97

Narrow-band imaging colonoscopy--a pilot feasibility study for the detection of polyps and correlation of surface patterns with polyp histologic diagnosis. Gastrointest Endosc (2007) 1.95

Correlation between narrow band imaging and nonneoplastic gastric pathology: a pilot feasibility trial. Gastrointest Endosc (2008) 1.85

Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology (2013) 1.72

Detection of Barrett's esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol (2006) 1.72

Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett's esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc (2010) 1.69

Group versus individual phone-based obesity treatment for rural women. Eat Behav (2009) 1.69

Accuracy of in vivo optical diagnosis of colon polyp histology by narrow-band imaging in predicting colonoscopy surveillance intervals. Gastrointest Endosc (2011) 1.61

Recognition of surface mucosal and vascular patterns of colon polyps by using narrow-band imaging: interobserver and intraobserver agreement and prediction of polyp histology. Gastrointest Endosc (2009) 1.60

Accuracy of narrow-band imaging in predicting colonoscopy surveillance intervals and histology of distal diminutive polyps: results from a multicenter, prospective trial. Gastrointest Endosc (2013) 1.58

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58

Beverage consumption patterns in elementary school aged children across a two-year period. J Am Coll Nutr (2005) 1.58

Two steps in Maf1-dependent repression of transcription by RNA polymerase III. J Biol Chem (2004) 1.58

Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiol Biomarkers Prev (2006) 1.56

Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol (2013) 1.56

Effects of sandy desertified land rehabilitation on soil carbon sequestration and aggregation in an arid region in China. J Environ Manage (2010) 1.54

High accuracy of narrow band imaging without magnification for the real-time characterization of polyp histology and its comparison with high-definition white light colonoscopy: a prospective study. Am J Gastroenterol (2009) 1.50

Sensitivity of endoscopic ultrasound, multidetector computed tomography, and magnetic resonance cholangiopancreatography in the diagnosis of pancreas divisum: a tertiary center experience. Pancreas (2013) 1.46

Higher adenoma detection rates with cap-assisted colonoscopy: a randomised controlled trial. Gut (2011) 1.45

A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.44

Randomized, controlled trial of standard-definition white-light, high-definition white-light, and narrow-band imaging colonoscopy for the detection of colon polyps and prediction of polyp histology. Gastrointest Endosc (2011) 1.44

Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointest Endosc (2005) 1.44

Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A (2007) 1.40

Effect of proton pump inhibitor therapy on inflammatory changes in the gastric cardia (carditis). Dig Dis Sci (2007) 1.39

Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35